QUANTITATIVE MASSIV PARALLELE PROTEOMIK
European patent · EP3488239 · In force
Register entry
- Publication number
- EP3488239
- Application number
- EP17748996
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 21, 2017
- Published
- May 29, 2019
- Granted
- Mar 25, 2026
- Protection ends at the latest
- Jul 20, 2037
- Next annual fee due
- Jul 31, 2026
- IPC classes
- C12Q 1/6804 (2018.01)G01N 33/58 (2006.01)C12Q 1/68 (2018.01)
- Priority
- US 201662365542 P 22.07.2016
- PCT application
- PCT/US2017/043273 21.07.2017
- PCT publication
- WO2018/017949 25.01.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 23, 2026
Owner
- Owner
- Verily Life Sciences LLC, 2999 Olympus Blvd, 10th Floor / Ste 1000, Dallas, TX 75019, USA → Verily Health Inc., 2999 Olympus Blvd, 10th Floor, Ste 1000, Dallas, Texas 75019, USA
Published in Swissreg on 23.04.2026
- Mar 25, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 25.03.2026
Parties
Inventor
PEIKON, Ian
Bethpage, NY 11714, US
TONG, Gary
South San Francisco, CA 94080, US
LIU, Daniel
South San Francisco, CA 94080, US
CHU, Ci
South San Francisco, CA 94080, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.